The PHIP mutation was associated with core neuropsychiatric symptoms, including anxiety and depression, whereas the CLCN4 mutation contributed to severe brain atrophy observed in neuroimaging, further exacerbating cognitive and behavioral deficits. Here, CLCN4 is linked to depressive symptom measurement.